Seawolf Therapeutics raises $100 million to advance DNA-based therapeutics
Statements (3)
- Neutral
Seawolf Therapeutics launched a new company with $100 million to fund non-viral gene therapies
- Bullish
Big-name investors poured $100 million into DNA therapeutics developer Seawolf
- Neutral
Seawolf Therapeutics raised $100 million to advance DNA-based therapeutics